GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Cash from Financing Activities for 5 consecutive years, with -$236.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities fell 117.34% year-over-year to -$236.0 million; the trailing twelve-month figure through Jun 2026 stood at -$673.0 million (down 194.52% YoY), and the FY2025 full-year result was $617.0 million, up 207.68% from the prior year.
• Cash from Financing Activities fell to -$236.0 million in Q2 2026 per GEHC's latest filing, from $21.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.4 billion in Q2 2025 and bottomed at -$1.3 billion in Q4 2024.
• Historically, Cash from Financing Activities has averaged -$81.7 million across 5 years, with a median of -$159.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities plunged 2332.43% in 2023, then surged 3908.33% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$37.0 million in 2022, then slumped by 2332.43% to -$900.0 million in 2023, then plunged by 41.89% to -$1.3 billion in 2024, then jumped by 77.06% to -$293.0 million in 2025, then gained by 19.45% to -$236.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$236.0 million, $21.0 million, and -$293.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.